上客户端，和病友交流
点击下载
返回
乳腺癌
Ammar Sukari M.D.

Ammar Sukari M.D.

外科
Karmanos cancer center

擅长疾病

临床新药咨询

通过咨询找到适合自己的药物

专家会诊咨询

专业、及时的一对一咨询

如果您的问题未能解决，您还可以选择：

医学顾问

极速问诊

2万名名医
7*24小时为您匹配
1对1

找专家

肿瘤专科专家
对症找医专科专治

专家介绍

2015-06-18 14:122145
 ·         Gender

·         Male

·         Multidisciplinary Team(s)

·         Breast Cancer 
Head & Neck Oncology 
Thoracic Oncology 

·         Department/Research Program(s)

·         Department of Oncology 

·         Cancer Type(s)

·         Ear Cancer 
Eye Cancer 
Nose Cancer 
Neck Cancer 
Oral Cavity Cancer (Mouth) 
Lung Cancer (Small Cell & Non-Small Cell) 
Esophageal Cancer 
Breast cancer 

·         Contact Info

·         Email:
sukaria@karmanos.org

 

来自 <http://www.karmanos.org/physicians/Ammar-Sukari?Disease=197&PageIndex=0&SortDirection=1>

 

·         Education

·         Fellowship
Medical Oncology, William Beaumont Hospital, Royal Oak, MI
Medical School
University of Aleppo Medical School
Residency
Internal Medicine, William Beaumont Hospital Royal Oak, MI

·         Professional Memberships/Associations

·         American Society of Clinical Oncology 
Michigan State Medical Society 
Syrian Physicians Association 

·         Board Certifications

·         American Board of Internal Medicine
Medical Oncology

·         Clinical Interests

·         Medical Oncologist 

·         Profile

·         Ammar Sukari, M.D., is a medical oncologist and member of the Head and Neck and Thoracic Multidisciplinary Teams at the Karmanos Cancer Center. He is also an assistant professor of internal medicine at Wayne State University School of Medicine. Dr. Sukari received a medical diploma from the University of Aleppo Medical School in Syria. He completed his first year residency in internal medicine at Al Assad University Hospital in Syria. Dr. Sukari also completed an internal medicine residency and medical oncology fellowship at William Beaumont Hospital in Royal Oak, MI. Dr. Sukari is board certified by the American Board of Medical oncology and the American Board of Internal Medicine. He is also a member of the American Society of Clinical Oncology, American Medical Association and the Michigan State Medical Society. Dr. Sukari joined the Karmanos Cancer Center in 2008.

·         Publications

·         Nodal pathologic features are prognostic in head and neck cancer patients undergoing chemoradiotherapy, Head & Neck, In Press. Authors: Christensen M, Paximadis P, Dyson G, Kamdar D, Sukari A, Lin HS, Yoo GH, Kim H,
Concurrent Chemoradiotherapy Improves Survival in Patients with Hypopharyngeal Cancer, International Journal of Radiation Oncology, In Press. Authors: Paximadis P, Yoo GH, Lin HS, Jacobs J, Sukari A, Dyson G, Christinsen M, Kim H,
L-00254-2011, "MDM2 inhibitor MI-219-Cisplatin Induces Apoptosis in Lung Cancer Cells Irrespective of the Mutational Status of p53" has been submitted to American Journal of Physiology - Lung Cellular and Molecular Physiology on 1st Aug 2011. Authors: ASFAR AZMI, Ammar Sukari, Mai'n Maitah, Amanda Sehmer, and Ramzi Mohammad
A phase II study examining the feasibility of long term use of low dose oral capecitabine (Xeloda®) in the adjuvant setting following definitive therapy in patients with newly diagnosed head and neck squamous cell carcinoma (manuscript in progress). Authors: Sukari A, Abrams J, Kafri Z, Almhanna K, Ensley JF, Kucuk O, KimH, Mulrenan H, Lin HS, Yoo GH,
Phase II Study of Docetaxel and Gemcitabine Combination in Patients with Previously Treated Recurrent or metastatic Squamous Cell Carcinoma of The Head and Neck (manuscript in progress). Authors: Kafri K, Sukari A, Yoo GH, Jacobs J, Kim H, Mulrenan H, Heilbrun LK, Smith D, Kucuk O,

1. 添加医学顾问微信，扫描☟二维码

2. 备注【癌种】进病友群

扫描预约专家问诊

专家科普

同类全球会诊
合作伙伴：